Paresthesia-Free Fast-Acting Subperception (FAST) Study
FAST
Study to Demonstrate the Value of Paresthesia-Free Fast-Acting Subperception (FAST) and Other SCS Therapies Using WaveWriter™ Spinal Cord Stimulator Systems in the Treatment of Chronic Pain
1 other identifier
interventional
177
1 country
13
Brief Summary
Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Feb 2021
Longer than P75 for not_applicable chronic-pain
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2020
CompletedFirst Posted
Study publicly available on registry
November 6, 2020
CompletedStudy Start
First participant enrolled
February 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2022
CompletedResults Posted
Study results publicly available
December 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
ExpectedMarch 5, 2026
March 1, 2026
1.8 years
October 31, 2020
December 14, 2023
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Targeted Pain Responder Rate
Proportion of subjects with 50% or greater reduction from Baseline Visit in average targeted pain intensity at 3 months post-activation
3 months post-activation
Study Arms (1)
WaveWriter Settings
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Chronic pain (predominantly neuropathic) of the trunk and/or limbs for at least 6 months with back pain greater or equal to leg pain.
- years of age or older when written informed consent is obtained
- Able to independently read and complete all questionnaires and assessments provided in English
- Signed a valid, IRB-approved informed consent form (ICF) provided in English
You may not qualify if:
- Any pain-related diagnosis or medical/psychological condition or external factors that, in the clinician's best judgment, might confound reporting of study outcomes
- Significant cognitive impairment that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
- Breast-feeding or planning to get pregnant during the course of the study or not using adequate contraception
- Participating, or intends to participate, in another clinical trial that may influence the data that will be collected for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
Vitamed Research
Palm Desert, California, 92260, United States
Denver Back Pain Specialists
Greenwood Village, Colorado, 80111, United States
Orlando Health Neuroscience Institute
Clermont, Florida, 34711, United States
The Orthopaedic Institute
Gainesville, Florida, 32607, United States
University of Chicago Hospital
Chicago, Illinois, 60637, United States
Goodman Campbell Brain and Spine
Carmel, Indiana, 46032, United States
Willis-Knighton River Cities Clinical Research Center
Shreveport, Louisiana, 71105, United States
Montefiore Medical Center
The Bronx, New York, 10461, United States
The Center for Clinical Research
Winston-Salem, North Carolina, 27103, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Pacific Sports and Spine, LLC
Eugene, Oregon, 97401, United States
PCPMG Clinical Research Unit, LLC
Greenville, South Carolina, 29601, United States
Acute and Chronic Pain Therapies
Bellevue, Washington, 98005, United States
Related Publications (1)
Anitescu M, Loudermilk E, North J, Wahezi S, Antony A, Leier T, Trainor D, Noles J, Moore G, Lee J, Paez J, Wilson D, Van Belleghem V, Goldberg E. Pain Relief and Multidimensional Outcomes of Fast-Acting Subperception Spinal Cord Stimulation Therapy for Chronic Pain: The FAST Prospective, Multicenter Study. Pain Ther. 2026 Mar 10. doi: 10.1007/s40122-026-00823-0. Online ahead of print.
PMID: 41803572DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sr. Director, Clinical Operations
- Organization
- Boston Scientific Corporation
Study Officials
- STUDY DIRECTOR
Natalie Bloom Lyons
Boston Scientific Corporation
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2020
First Posted
November 6, 2020
Study Start
February 10, 2021
Primary Completion
December 14, 2022
Study Completion (Estimated)
March 1, 2029
Last Updated
March 5, 2026
Results First Posted
December 29, 2023
Record last verified: 2026-03